Annual CFI
$61.50 M
+$125.39 M+196.25%
31 December 2023
Summary:
XBiotech annual cash flow from investing activities is currently $61.50 million, with the most recent change of +$125.39 million (+196.25%) on 31 December 2023. During the last 3 years, it has risen by +$65.22 million (+1750.04%). XBIT annual CFI is now -90.89% below its all-time high of $674.80 million, reached on 31 December 2019.XBIT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$338.00 K
+$289.00 K+46.09%
30 September 2024
Summary:
XBiotech quarterly cash flow from investing activities is currently -$338.00 thousand, with the most recent change of +$289.00 thousand (+46.09%) on 30 September 2024. Over the past year, it has dropped by -$62.16 million (-100.55%). XBIT quarterly CFI is now -100.05% below its all-time high of $674.99 million, reached on 31 December 2019.XBIT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$1.33 M
-$62.16 M-102.19%
30 September 2024
Summary:
XBiotech TTM cash flow from investing activities is currently -$1.33 million, with the most recent change of -$62.16 million (-102.19%) on 30 September 2024. Over the past year, it has dropped by -$59.04 million (-102.31%). XBIT TTM CFI is now -100.20% below its all-time high of $674.80 million, reached on 31 December 2019.XBIT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XBIT Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +196.3% | -100.5% | -102.3% |
| 3 y3 years | +1750.0% | +51.7% | +74.7% |
| 5 y5 years | +10000.0% | -109.9% | -548.1% |
XBIT Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +196.3% | -100.5% | +99.4% | -102.2% | +97.9% |
| 5 y | 5 years | -90.9% | +196.3% | -100.0% | +99.4% | -100.2% | +97.9% |
| alltime | all time | -90.9% | +196.3% | -100.0% | +99.4% | -100.2% | +97.9% |
XBiotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$338.00 K(-46.1%) | -$1.33 M(-102.2%) |
| June 2024 | - | -$627.00 K(+145.9%) | $60.83 M(-0.7%) |
| Mar 2024 | - | -$255.00 K(+121.7%) | $61.25 M(-0.4%) |
| Dec 2023 | $61.50 M(-196.3%) | -$115.00 K(-100.2%) | $61.50 M(+6.6%) |
| Sept 2023 | - | $61.83 M(<-9900.0%) | $57.70 M(-190.4%) |
| June 2023 | - | -$208.00 K(+3366.7%) | -$63.86 M(+0.2%) |
| Mar 2023 | - | -$6000.00(-99.8%) | -$63.74 M(-0.2%) |
| Dec 2022 | -$63.89 M(+1712.5%) | -$3.91 M(-93.5%) | -$63.89 M(+5.7%) |
| Sept 2022 | - | -$59.74 M(>+9900.0%) | -$60.46 M(+4160.8%) |
| June 2022 | - | -$82.00 K(-49.1%) | -$1.42 M(-53.5%) |
| Mar 2022 | - | -$161.00 K(-66.2%) | -$3.05 M(-13.5%) |
| Dec 2021 | -$3.52 M(-5.4%) | -$476.00 K(-32.0%) | -$3.52 M(-33.1%) |
| Sept 2021 | - | -$700.00 K(-59.1%) | -$5.27 M(+0.1%) |
| June 2021 | - | -$1.71 M(+168.8%) | -$5.26 M(+32.4%) |
| Mar 2021 | - | -$637.00 K(-71.3%) | -$3.98 M(+6.7%) |
| Dec 2020 | -$3.73 M(-100.6%) | -$2.22 M(+219.6%) | -$3.73 M(-100.6%) |
| Sept 2020 | - | -$694.00 K(+62.9%) | $673.49 M(-0.1%) |
| June 2020 | - | -$426.00 K(+9.5%) | $674.02 M(-0.1%) |
| Mar 2020 | - | -$389.00 K(-100.1%) | $674.41 M(-0.1%) |
| Dec 2019 | $674.80 M | $674.99 M(<-9900.0%) | $674.80 M(<-9900.0%) |
| Sept 2019 | - | -$161.00 K(+419.4%) | -$206.00 K(+167.5%) |
| June 2019 | - | -$31.00 K(+416.7%) | -$77.00 K(-18.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$6000.00(-25.0%) | -$94.00 K(-23.0%) |
| Dec 2018 | -$122.00 K(-91.3%) | -$8000.00(-75.0%) | -$122.00 K(-66.8%) |
| Sept 2018 | - | -$32.00 K(-33.3%) | -$368.00 K(-38.4%) |
| June 2018 | - | -$48.00 K(+41.2%) | -$597.00 K(-28.2%) |
| Mar 2018 | - | -$34.00 K(-86.6%) | -$832.00 K(-40.8%) |
| Dec 2017 | -$1.41 M(-89.9%) | -$254.00 K(-2.7%) | -$1.41 M(-55.0%) |
| Sept 2017 | - | -$261.00 K(-7.8%) | -$3.12 M(-48.3%) |
| June 2017 | - | -$283.00 K(-53.4%) | -$6.03 M(-48.0%) |
| Mar 2017 | - | -$607.00 K(-69.2%) | -$11.60 M(-16.6%) |
| Dec 2016 | -$13.91 M(+33.9%) | -$1.97 M(-38.0%) | -$13.91 M(-11.3%) |
| Sept 2016 | - | -$3.17 M(-45.8%) | -$15.69 M(-7.5%) |
| June 2016 | - | -$5.86 M(+100.8%) | -$16.96 M(+33.1%) |
| Mar 2016 | - | -$2.92 M(-22.1%) | -$12.74 M(+22.6%) |
| Dec 2015 | -$10.39 M(+643.9%) | -$3.75 M(-15.6%) | -$10.39 M(+44.4%) |
| Sept 2015 | - | -$4.44 M(+170.7%) | -$7.20 M(+118.8%) |
| June 2015 | - | -$1.64 M(+187.0%) | -$3.29 M(+72.3%) |
| Mar 2015 | - | -$571.00 K(+3.6%) | -$1.91 M(+36.7%) |
| Dec 2014 | -$1.40 M(+2267.8%) | -$551.00 K(+4.2%) | -$1.40 M(+65.1%) |
| Sept 2014 | - | -$529.00 K(+104.2%) | -$846.00 K(+166.9%) |
| June 2014 | - | -$259.00 K(+346.6%) | -$317.00 K(+446.6%) |
| Mar 2014 | - | -$58.00 K | -$58.00 K |
| Dec 2013 | -$59.00 K(-89.3%) | - | - |
| Dec 2012 | -$550.00 K | - | - |
FAQ
- What is XBiotech annual cash flow from investing activities?
- What is the all time high annual CFI for XBiotech?
- What is XBiotech annual CFI year-on-year change?
- What is XBiotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for XBiotech?
- What is XBiotech quarterly CFI year-on-year change?
- What is XBiotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for XBiotech?
- What is XBiotech TTM CFI year-on-year change?
What is XBiotech annual cash flow from investing activities?
The current annual CFI of XBIT is $61.50 M
What is the all time high annual CFI for XBiotech?
XBiotech all-time high annual cash flow from investing activities is $674.80 M
What is XBiotech annual CFI year-on-year change?
Over the past year, XBIT annual cash flow from investing activities has changed by +$125.39 M (+196.25%)
What is XBiotech quarterly cash flow from investing activities?
The current quarterly CFI of XBIT is -$338.00 K
What is the all time high quarterly CFI for XBiotech?
XBiotech all-time high quarterly cash flow from investing activities is $674.99 M
What is XBiotech quarterly CFI year-on-year change?
Over the past year, XBIT quarterly cash flow from investing activities has changed by -$62.16 M (-100.55%)
What is XBiotech TTM cash flow from investing activities?
The current TTM CFI of XBIT is -$1.33 M
What is the all time high TTM CFI for XBiotech?
XBiotech all-time high TTM cash flow from investing activities is $674.80 M
What is XBiotech TTM CFI year-on-year change?
Over the past year, XBIT TTM cash flow from investing activities has changed by -$59.04 M (-102.31%)